- Science
- Clinical Trials
- Guide to Clinical Trials Your participation makes a difference
- Clinical Trials in Children Designed to improve kids' health
- Data and Results Sharing our Results
- Integrity and Transparency Building Trust
- Diversity Equity and Representation
- Plain Language Study Results Trial Result Summaries
- Expanded Access & Compassionate Use Possible Treatment Options
- Find a Trial
- Areas of Focus
- Rare Disease Smaller populations but big impact
- Internal Medicine Extending lifespans worldwide
- Inflammation & Immunology Treatment at the molecular level
- Vaccines Preventing the spread of infections
- Oncology The science of optimism
- Anti Infectives Combatting an evolving risk
- Areas of Innovation
- Gene Therapy Breakthroughs become treatments
- Medicinal Sciences The next generation of science
- Precision Medicine Developing tailored medicines
- Maternal Immunization Protecting newborns at the start
- mRNA Technology Unleashing the next wave of scientific innovations
- Diseases & Conditions
- Coronavirus Resources
- Product Pipeline
- Research Sites
- Clinical Trials
- Products
- How Drugs are Made
- Branded vs. Generic Learn the difference
- Biologics & Biosimilars Cures found in nature
- Commitment to Quality Maintaining the highest standards
- Global Supply Strategic manufacturing locations
- Manufacturing Sites Where medicine is made in the U.S.
- Medicine Safety
- Health Literacy Learning to be well
- Treatment Choices Learning about treatment decisions
- Partnering With Patients Helping others by reporting side effects
- Tips for Patients Preventing medication errors
- Reporting Adverse Events
- Counterfeiting Preventing medication errors
- Product Safety
- Product List
- Product Contacts
- PfizerPro for Professionals
- Patient Assistance Programs
- Distributors
- How Drugs are Made
- Stories
- Newsroom
- About
- People
- Executives Our senior-most leadership
- Board Members The people steering our company
- Scientists Our experts making discoveries
- Patient Stories Our patients
- Colleague Stories Our colleagues
- Responsibility
- Ethics & Compliance Each of us is responsible
- Responsible Business Breakthroughs that change patients’ lives
- Patient Advocacy & Engagement Putting Patients First
- Global Impact Meeting urgent needs worldwide
- Diversity, Equity, and Inclusion Everyone has something to offer
- Environmental Sustainability Our responsiblity to the environment
- Human Rights Furthering dignity and worth
- Health & Safety
- Intellectual Property The benefits of fair competition
- EHS Governance
- Misinformation
- Programs & Policies
- Grants Support for independent research
- Political Partnership Supporting like-minded organizations
- Working with Healthcare Professionals Collaboration to improve lives
- Prescription Value & Pricing How to lower patient costs
- Privacy Principles Commitment to personal data privacy
- Ready for Cures Improving Access to Medicines
- Transparency in Grants Committed to Disclosure
- Policy Positions
- Investors
- Investors Overview Information for stockholders
- Why Invest Why to join us in our mission
- Events & Presentations Calendar of upcoming events
- Financial Reports Quarterly reports and more
- Investor News Announcements about our performance
- Stock Information Charts and data
- Shareholder Services Information on stock transactions
- Corporate Governance
- Corporate Governance Overview Gaining insight into our performance
- Board Committees & Charters Defining the corporate structure
- The Pfizer Board Policies Ensuring ethical leadership
- Corporate Governance FAQs Learn more about our approach
- Contact Our Directors Email any of our Directors
- Purpose
- History
- Careers
- Partners
- People
Executive Leadership
Doug Lankler
Chief Legal Officer, Executive Vice President
Douglas M. Lankler is Executive Vice President and Chief Legal Officer of Pfizer Inc. Doug reports to the Chairman and Chief Executive Officer. He has been with Pfizer since 1999, has been a member of Pfizer’s management team since 2009, and has led the legal division since 2013.
As Chief Legal Officer, Doug supervises all aspects of Pfizer’s legal division. He has responsibility for legal aspects of corporate governance, commercial, compliance, litigation, business development, research, labor, and intellectual property issues.
Doug is a former Assistant United States Attorney for the Southern District of New York, where he prosecuted corporate and organized crime, white collar fraud, and terrorism. In 1999, he received the Attorney General’s Distinguished Service Award.
Doug is a graduate of the State University of New York at Albany and Cornell Law School.
Other People In Executive Leadership
Dr. Albert Bourla
Chairman and Chief Executive Officer
Andrew Baum, BM ChB
Chief Strategy and Innovation Officer, Executive Vice President
Chris Boshoff, MD, PhD
Chief Scientific Officer and President, Research & Development
Alexandre de Germay
Chief International Commercial Officer, Executive Vice President
Dave Denton
Chief Financial Officer and Executive Vice President
Lidia Fonseca
Chief Digital and Technology Officer, Executive Vice President
Lindsay Havern
Senior Vice President of Executive Operations and Chief of Staff and Counsel to the Chairman and CEO
Aamir Malik
Chief U.S. Commercial Officer, Executive Vice President
Mike McDermott
Chief Global Supply and Quality Officer, Executive Vice President
Payal Sahni Becher
Chief People Experience Officer, Executive Vice President
Sally Susman
Chief Corporate Affairs Officer, Executive Vice President
Off
Executive Leadership
Doug Lankler
Chief Legal Officer, Executive Vice President
Douglas M. Lankler is Executive Vice President and Chief Legal Officer of Pfizer Inc. Doug reports to the Chairman and Chief Executive Officer. He has been with Pfizer since 1999, has been a member of Pfizer’s management team since 2009, and has led the legal division since 2013.
As Chief Legal Officer, Doug supervises all aspects of Pfizer’s legal division. He has responsibility for legal aspects of corporate governance, commercial, compliance, litigation, business development, research, labor, and intellectual property issues.
Doug is a former Assistant United States Attorney for the Southern District of New York, where he prosecuted corporate and organized crime, white collar fraud, and terrorism. In 1999, he received the Attorney General’s Distinguished Service Award.
Doug is a graduate of the State University of New York at Albany and Cornell Law School.
Other People In Executive Leadership
Dr. Albert Bourla
Chairman and Chief Executive Officer
Andrew Baum, BM ChB
Chief Strategy and Innovation Officer, Executive Vice President
Chris Boshoff, MD, PhD
Chief Scientific Officer and President, Research & Development
Alexandre de Germay
Chief International Commercial Officer, Executive Vice President
Dave Denton
Chief Financial Officer and Executive Vice President
Lidia Fonseca
Chief Digital and Technology Officer, Executive Vice President
Lindsay Havern
Senior Vice President of Executive Operations and Chief of Staff and Counsel to the Chairman and CEO
Aamir Malik
Chief U.S. Commercial Officer, Executive Vice President
Mike McDermott
Chief Global Supply and Quality Officer, Executive Vice President
Payal Sahni Becher
Chief People Experience Officer, Executive Vice President
Sally Susman
Chief Corporate Affairs Officer, Executive Vice President
Off